In such a model, addition of T0901317 restores insulin-stimulated glucose up-take, fatty acid synthase expression and counteracts metabolic disorder by decreasing secretion of the pro-inflammatory cytokine IL6 (67). The gene discussed is INS; the disease is metabolic disease.